{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:55:51Z","timestamp":1773834951312,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Physiogenex SAS"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.atherosclerosis.2014.01.028","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:16:12Z","timestamp":1390436172000},"page":"359-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters"],"prefix":"10.1016","volume":"233","author":[{"given":"Fran\u00e7ois","family":"Briand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9310-6661","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Prunet-Marcassus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9ment","family":"Costard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Muzotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Sordello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Sulpice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2174\/1381612811319170022","article-title":"The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease","volume":"19","author":"Bochem","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib3","first-page":"289","article-title":"The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport","volume":"11","author":"Briand","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrendo.2011.235","article-title":"The emerging role of HDL in glucose metabolism","volume":"8","author":"Drew","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCULATIONAHA.111.018259","article-title":"Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial","volume":"124","author":"Barter","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/ATVBAHA.112.252932","article-title":"Up regulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamsters","volume":"33","author":"Briand","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib8","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1194\/jlr.M016410","article-title":"Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters","volume":"52","author":"Castro-Perez","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cbpa.2006.10.029","article-title":"Distribution patterns of the glucose transporters GLUT4 and GLUT1 in skeletal muscles of rats (Rattus norvegicus), pigs (Sus scrofa), cows (Bos taurus), adult goats, goat kids (Capra hircus), and camels (Camelus dromedarius)","volume":"146","author":"Duehlmeier","year":"2007","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib10","doi-asserted-by":"crossref","first-page":"e23556","DOI":"10.1371\/journal.pone.0023556","article-title":"High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1194\/jlr.P012518","article-title":"Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus","volume":"52","author":"Drew","year":"2011","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2119\/molmed.2012.00113","article-title":"Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice","volume":"18","author":"Karavia","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib13","article-title":"Pleiotropic effects of HDL: towards new therapeutic areas for HDL-targeted interventions","author":"Gordts","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3945\/an.112.002089","article-title":"Regulation of hepatic glucose uptake and storage in\u00a0vivo","volume":"3","author":"Moore","year":"2012","journal-title":"Adv Nutr"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib15","first-page":"H643","article-title":"Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR","volume":"277","author":"Russell","year":"1999","journal-title":"Am J Phys"},{"key":"10.1016\/j.atherosclerosis.2014.01.028_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCRESAHA.113.300689","article-title":"Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion","volume":"113","author":"Siebel","year":"2013","journal-title":"Circ Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014000537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:34:58Z","timestamp":1758155698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0021915014000537"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raising HDL with CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}